Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,402 | 12,387 | 15,348 | 17,390 | 21,462 |
| TOTAL | $83,100 | $13,020 | $15,548 | $17,925 | $22,269 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1 | 3 | 4 | 5 |
| Intangibles | 14,869 | 14,869 | 14,869 | 14,869 | 14,869 |
| Other Non-Current Assets | 0 | 201 | 0 | 0 | 0 |
| TOTAL | $14,869 | $15,072 | $14,872 | $14,874 | $14,875 |
| Total Assets | $97,969 | $28,092 | $30,420 | $32,798 | $37,144 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 640 | 945 | 897 | 640 | 1,608 |
| Accrued Expenses | 1,651 | 1,728 | 1,632 | 1,307 | 1,229 |
| TOTAL | $2,291 | $2,672 | $2,529 | $1,947 | $2,837 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 236,427 | 60,000 | 60,000 | 60,000 | 60,000 |
| TOTAL | $236,427 | $60,000 | $60,000 | $60,000 | $60,000 |
| Total Liabilities | $238,717 | $62,672 | $62,529 | $61,947 | $62,837 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,274 | 6,993 | 6,993 | 6,993 | 6,993 |
| Common Shares | 4 | 1 | 1 | 1 | 1 |
| Retained earnings | -688,800 | -405,132 | -402,388 | -399,130 | -395,377 |
| TOTAL | $-140,748 | $-34,580 | $-32,109 | $-29,149 | $-25,693 |
| Total Liabilities And Equity | $97,969 | $28,092 | $30,420 | $32,798 | $37,144 |